Despite Adaptive Biotechnologies Corp [ADPT]’s great opportunity, the stock is a bit overvalued
In yesterday’s Wall Street session, Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares traded at $3.51, down -18.18% from the previous session. 8 analysts cover Adaptive Biotechnologies Corp (NASDAQ:ADPT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $13.00 and a […]
